Abiopharma

Olema Oncology to Participate in Upcoming Investor Conferences

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy

BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025

Westlake - Westlake Corporation Declares Quarterly Dividend

Westlake Corporation Declares Quarterly Dividend

BeiGene annonce ses résultats financiers et ses mises à jour commerciales pour le premier trimestre de 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update